
Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc. (LYRA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LYRA · as of Jun 9, 2026
Key Statistics
Explore Lyra Therapeutics, Inc. Data
lyra stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 40.0%
The LYRA analyst consensus is Hold, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $0.50, representing +13.61% upside from the current price of $0.44.
Competitors & Peers
lyra competitorsStock Performance
Full HistoryAbout Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc. operates as a clinical-stage biotechnology company, primarily focused on the creation and commercialization of anti-inflammatory treatments for individuals suffering from chron…
what is lyra therapeutics, inc. · lyra stock overview · lyra therapeutics, inc. company profile · who is lyra therapeutics, inc. ceo · lyra NASDAQ · lyra therapeutics, inc. headquarters · lyra therapeutics, inc. business segments
About Stock Overview & Key Data
Lyra Therapeutics, Inc. (LYRA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 1, 2020. As of the latest trading session, LYRA stock price is $0.44, with a market capitalization of $781,126. The stock has returned -89.81% over the past 12 months and -85.71% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Lyra Therapeutics, Inc. stock is Hold, with an average 12-month price target of $0.50. In fiscal year 2025, Lyra Therapeutics, Inc. reported revenue of $398000.00 and net income of -$28.9M. For detailed data — including Lyra Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lyra Therapeutics, Inc. (LYRA) stock price is $0.44. The stock is traded on NASDAQ under the ticker symbol LYRA. The 52-week range is $0.44 – $37.50.